Novo clinches AI-driven drug deal worth as much as $2.7B

By Bloomberg
| September 26, 2023

Novo Nordisk A/S agreed to partner with the U.S. technology company Valo Health Inc. to use AI to find new drugs in a deal that could be worth as much as $2.7 billion.

Full story

#1

Physicians are in short supply. They are costly. Is the APP the answer to the CMO's workforce and budget challenges? ...

Hospital leaders are increasingly turning to automation to streamline revenue cycle operations, but should some processes be left behind? ...